Galectin Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
AbbVie 2.64 0.07 Sep/2026
Bristol-Myers Squibb 4.04 0.32 Sep/2026
Galectin Therapeutics 0 0 Mar/2025
Gilead Sciences 2.18 0.37 Sep/2026
Merck 2.34 0.28 Sep/2026